Activity of an alkaline 'cleaner' in the inactivation of the scrapie agent

Journal of Hospital Infection

Volumn 57, Issue 1, 2004, Pages 80-84

  Baier, M ^a   Schwarz, A ^a   Mielke, M ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Cleaner; Destabilization; Inactivation; Prions; Reprocessing; Surgical instruments

Indexed keywords

DOMESTIC CHEMICAL; PRION PROTEIN; PROTEINASE K;

ALKALINITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DENATURATION; DEVICE; DISEASE CARRIER; HAMSTER; INCUBATION TIME; INOCULATION; NONHUMAN; PRION DISEASE; PROTEIN FOLDING; RISK REDUCTION; SCRAPIE AGENT; SYMPTOM; VIRUS DETECTION; VIRUS INACTIVATION; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

ALKALIES; ANIMALS; CRICETINAE; DECONTAMINATION; DETERGENTS; ENDOPEPTIDASE K; INFECTION CONTROL; MICROBIAL VIABILITY; PRION DISEASES; PRPSC PROTEINS; STERILIZATION; SURGICAL INSTRUMENTS;

EID: 2342454368     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2004.01.013     Document Type: Article

References (32)

1. Johnson R.T. Gibbs C.J. Ceutzfeldt-Jakob disease and related transmissible spongiform encephalopathies N Engl J Med 339 1998 1994-2004
2. Prusiner S.B. Prions Proc Nat Acad Sci USA 95 1998 13363-13383
3. World Health Organization. WHO infection control guidelines for transmissible spongiform encephalopathies. Report of a WHO consultation, Geneva, Switzerland. 23-26 March 1999.
4. Rutala W.A. Weber D.J. Creutzfeldt-Jakob disease; recommendations for disinfection and sterilization Clin Infect Dis 32 2001 1348-1356
5. Rutala W.A. Weber D.J. Creutzfeldt-Jakob disease: risks and prevention of nosocomial acquisition Infect Control Today 5 2001 47-50
6. Brown P. Preece M. Brandel J.-P. et al. Iatrogenic Creutzfeld-Jakob disease at the millennium Neurology 55 2000 1075-1081
7. Collinge J. Variant Creutzfeldt-Jakob disease Lancet 354 1999 317-323
8. Brown P. Will R.G. Bradley R. et al. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns Emerg Infect Dis 7 2001 1-16
9. Coulthart M.B. Cashman N.R. Variant Creutzfeldt-Jakob disease: a summary of current scientific knowledge in relation to public health Can Med Assoc J 165 2001 51-58
10. Will R.G. Ironside J.W. Zeidler M. et al. A new variant of Creutzfeldt-Jakob disease in the UK Lancet 347 1996 921-925
11. Will R.G. Knight R.S. Zeidler M. et al. Reporting of suspect new variant Creutzfeldt-Jakob disease Lancet 349 1997 847
12. Bruce M.E. Will R.G. Ironside J.W. et al. Transmissions to mice indicate that new variant CJD is caused by the BSE agent Nature 389 1997 498-501
13. Hill A.F. Desbruslais M. Joiner S. et al. The same prion strain causes, vCJD and BSE Nature 389 1997 449-450
14. Scott M.R. Will R. Ironside J.W. et al. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans Proc Nat Acad Sci USA 96 1999 15137-15142
15. Brown P. Bovine spongiform encephalopathy and variant Creutzfeld-Jakob disease BMJ 1322 2001 841-844
16. Lasmezas C.I. Fournier J.-G. Nouvel V. et al. Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with the Creutzfeld-Jakob disease: implication for human health Proc Natl Acad Sci USA 96 2001 4142-4147
17. Kawashima T. Furukawa H. Katsumi D. Iwaki T. Diagnosis of new variant Creutzfeld-Jakob disease by tonsil biopsy Lancet 350 1997 68-69
18. Hill A.F. Butterworth R.J. Joiner S. et al. Investigation of Creutzfeld-Jakob disease and other human prion diseases with tonsil biopsy samples Lancet 353 1999 183-189
19. Hilton D.A. fathers E. Edwards P. et al. Prion immunoreactivity in appendix before clinical onset of Creutzfeldt-Jakob disease Lancet 352 1998 703-704
20. Wadsworth J.D.F. Joiner S. Hill A.F. et al. Tissue distribution of protease resistant prior protein in variant Creutzfeld-Jakob disease using a highly sensitive immunoblotting assay Lancet 358 2001 171-180
21. Bruce M.E. McConnell I. Will R.G. Ironside J.W. Detection of variant Creutzfeld-Jakob disease infectivity in extraneural tissues Lancet 358 2001 208-209
22. Hilton D.A. Ghani A.C. Conyers L. et al. Accumulation of prion protein in tonsil and appendix: review of tissue samples BMJ 325 2002 632-633
23. Department of Health, Economics and operational division Risk assessment for transmission of vCJD via surgical instruments: a modelling approach and numerical scenarios 2001 Government Operational Research Service London
24. Abschlussbericht der Task Force vCJK Die Variante der Creutzfeldt-Jakob Krankheit (vCJK) Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 45 2002 376-394
25. Favero M.S. Current issues in hospital hygiene and sterilization technology J Infect Control (Asia Pacific Ed) 1 1998 8-10
26. Geertsma R.E. van Asten J.A.A.M. Sterilization of prions: requirements, complications, implication Zentr Steril 3 1995 385-394
27. Bagg J. Sweeney C.P. Roy K.M. et al. Cross-infection control measures and the treatment of patients at risk of Creutzfeld-Jakob disease in UK general dental practice Br Dent J 191 2001 87-90
28. Tullo A. Buckley R. Painter M. CJD and the eye Eye 14 2000 259-260
29. Kirkpatrick W.N.A. Waterhouse N. Pharyngoplasty and the risk of variant CJD transmission Br J Plast Surg 54 2001 552-561
30. Flechsig E. Hegyi I. Enari M. et al. Transmission of scrapie by steel-surface bound prions Mol Med 7 2001 679-684
31. Riemer C. Queck I. Simon D. Kurth R. Baier M. Identification of upregulated genes in scrapie-infected brain tissue J Virol 74 2000 10245-10248
32. Baier M. Norley S. Schultz J. Burwinkel M. Schwarz A. Riemer C. Prion diseases: infectious and lethal doses by oral challenge J Gen Virol 84 2003 1927-1929